NW Recovery Centers Logo
News

West Virginia Is Hiring Six Universities to Grade Its Opioid Settlement Spending

West Virginia's opioid settlement foundation now has six universities reviewing grants and measuring results, after nearly $40 million went to 171 projects.

7 min readBy NW Recovery Centers Editorial Team
Editorial illustration of university research buildings beside a state outline and grant documents

West Virginia's opioid settlement foundation spent Monday introducing the people who will now decide whether its money worked. At the Robert H. Mollohan Research Center in Fairmont, the West Virginia First Foundation gathered Governor Patrick Morrisey, its own board chairman and executive director, and the presidents of Marshall University, West Virginia University and West Virginia Wesleyan, alongside representatives of the University of Charleston, Johns Hopkins University and the University of Notre Dame.

The event, billed as "Evidence to Impact: Strategic Partnerships in Higher Education and Research," formalized something that had been informal: six academic institutions now sit inside the foundation's decision-making. They review grant applications, run the statewide needs assessment that sets funding priorities, and track what happens to the programs that get paid.

The timing is the story. The foundation says it has already awarded nearly $40 million across 171 projects, according to the grants tracker on its own website. Most of those decisions were made before this evaluation structure existed. Only the applications that come next will be graded by outside researchers before the cheque is cut.

The money and the mandate

The West Virginia First Foundation was created by the West Virginia First Memorandum of Understanding, an agreement among the state, its counties and its municipalities for allocating opioid settlement funds. The foundation is a private nonprofit, not an agency, which is why its grantmaking rules are set by its board rather than by procurement law. Its grant programs run under names like the Initial Opportunity Grant, the Momentum Initiative Grant and the Community Catalyst Grant, and they are aimed at prevention, treatment, recovery housing, reentry and youth programs.

That structure is common across the country, and it has a known weak point: a settlement foundation can move money quickly, but it has no built-in research capacity. Foundations that tried to buy that capacity late have often ended up commissioning one-off evaluations of programs already running. West Virginia's $85 million settlement allocation to treatment and prevention programs was covered earlier this year; Monday's announcement is about who checks whether that money did anything.

Monday's announcement is West Virginia's answer to that gap, and it splits the work into three functions that press coverage tends to blur into one phrase — "data-driven."

Three jobs, not one

Assessing need. West Virginia University's Health Affairs Institute is leading what the foundation calls the West Virginia Wayfinder statewide needs assessment, using data to identify gaps in prevention, treatment and recovery services and to inform the foundation's funding priorities. This is the part that determines which counties and which service types the next round of money goes to.

Reviewing applications before award. Marshall University's Center of Excellence for Recovery is supporting the Community Catalyst Grant review process. West Virginia Wesleyan's Center for Addiction & Trauma is supplying academic reviewers for the same program. The University of Notre Dame's Wilson Sheehan Lab for Economic Opportunities provides what the foundation describes as independent, research-informed evaluation of grant applications to support objective funding decisions.

Measuring after the money arrives. Marshall is also helping shape how outcomes are tracked across funded initiatives. The University of Charleston is building on a naloxone distribution program originally established by its School of Pharmacy, using resources from the Teva opioid settlement, and will track naloxone utilization and associated outcomes. Johns Hopkins supplied foundational guidance on the foundation's evidence-based approach, from application intake through outcomes measurement.

Four of the six institutions are in-state. Johns Hopkins and Notre Dame are not — a detail worth noticing in a state that has spent years arguing that outside expertise arrives with its own assumptions about Appalachia.

The claim being tested

"Behind every dollar we invest is a West Virginian fighting for recovery, a family hoping for a second chance, or a community working to heal," the foundation's executive director, Jonathan Board, said in the release. He described the partnerships as an attempt to go "beyond simply funding programs to understanding what works, measuring results, and making decisions that will change the course of this crisis for generations to come."

That is a testable claim, and West Virginia has the data to test it against. Federal provisional counts from the CDC's surveillance system put the state's overdose deaths at 609 for the 12 months ending in June 2026, down from 685 for the 12 months ending in November 2025. Opioid deaths in the same series fell from 504 to 443, and deaths involving synthetic opioids other than methadone fell from 455 to 397. Deaths involving psychostimulants such as methamphetamine, which increasingly appear alongside fentanyl rather than instead of it, fell more slowly — from 367 to 298.

Two cautions belong next to those numbers. First, the most recent month in the series is provisional: about 0.4% of June 2026 death records were still pending investigation, so the figure will move. Second, and more important, overdose deaths are falling almost everywhere in the United States right now. A decline in West Virginia is not evidence that any particular grant worked, and the foundation's new partners will be under pressure to say so plainly rather than claim the curve.

Nothing in Monday's announcement sets a target, publishes a metric set, or commits the foundation to releasing outcome data program by program. Those are the commitments that would let a resident check the claim. Until they exist, "measuring results" is a design, not a finding.

What residents and local organizations can use

The Community Catalyst Grant is the route most local organizations take, and its review panel now includes academic reviewers from Marshall and West Virginia Wesleyan — which means applications are more likely to be read against published evidence standards than against who attended the meeting.

The foundation's board meets quarterly and takes public comment. The next meeting is December 10, 2026, and it is open to the public virtually; the foundation posts the link and accepts media questions at media@wvfirst.org. For anyone who wants to know where settlement dollars went in their county, the foundation publishes a searchable list of past awardees by region, plus local government reporting and financial reports.

For families looking for treatment rather than grant paperwork, the practical question to ask any program is whether it is settlement-funded and what its outcome data show. Our guide to Medicaid-funded addiction treatment covers what the coverage actually pays for in states that expanded it. West Virginia's own 24/7 helpline, HELP4WV, takes calls, chats and texts at 1-844-435-7498 and is staffed largely by peer recovery coaches. The national SAMHSA helpline is 1-800-662-4357, and 988 handles mental health crises. Naloxone training was part of Monday's event itself — the University of Charleston ran a session for the foundation's board and staff afterward — and local health departments and the Charleston program distribute supplies.

What's next

The Wayfinder assessment is the item to watch, because it decides where the next round goes and it will be published with county-level gaps attached. After that, the test is whether the new review panels change anything: whether applications get rejected that would previously have been funded, whether outcome reporting becomes a condition of the money, and whether the foundation publishes results it does not like.

West Virginia moved faster than most states to get settlement money out the door. Its board chairman, Greg Duckworth, said Monday that the foundation has been "one of the fastest opioid settlement foundations in the nation to get funding into the hands of those making a difference." Speed was the first phase. The universities are the second, and it is the one that decides whether the first phase can be defended in five years.

Families in the middle of this do not have five years. The helplines above answer today, and treatment access does not depend on a needs assessment being finished.

Sources